MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

507555

Report Date :

07.05.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

SYMBIO GENERRICS INDIA PRIVATE LIMITED

 

 

Registered Office :

Ground Floor, Wing-A, DP-21, SIDCO Industrial Estate, Thirumazhisai, Chennai – 600124, Tamilnadu

Tel. No.:

91-44-26812287/ 25324300

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

30.05.2011

 

 

Com. Reg. No.:

18-080853

 

 

Capital Investment / Paid-up Capital :

INR 9.900 Million

 

 

CIN No.:

[Company Identification No.]

U74990TN2011PTC080853

 

 

IEC No.:

[Import-Export Code No.]

Not Divulged

 

 

GSTN :

[Goods & Service Tax Registration No.]

33AAPCS9972B2ZY

 

 

TIN No.:

33970442848

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAPCS9972B

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Wholesale Trader of Pharmaceuticals, Nutraceuticals, feed and food supplements, feed additives, serum, bulk drugs and intermediate. [Registered Activity]

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Maximum Credit Limit :

USD 174100

 

 

Status :

Good

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 2011 and is a trader of pharmaceuticals, nutraceuticals, feed and food supplements, bulk drugs etc.

 

 For the financial year 2017, the company has achieved a massive increase in the revenue and has maintained an average profit margin of 3.23%.

 

The sound financial profile of the company is marked by adequate net worth base along with comfortable debt balance sheet profile.

 

Rating takes into consideration the subject’s healthy Earnings per Share of INR 27.65 against the Face Value of INR 10.

 

Payment seems to be usually correct.

 

In view of aforesaid the company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2018.

 

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 07.05.2018.

 

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

INFORMATION DECLINED BY

 

Name :

Mr. Abhijit Govindrao Kale

Designation :

Director

Contact No.:

91-9820611471

Date :

05.05.2018

 

 

LOCATIONS

 

Registered Office :

Ground Floor, Wing-A, DP-21, SIDCO Industrial Estate, Thirumazhisai, Chennai – 600124, Tamilnadu, India

Tel. No.:

91-44-26812287/ 25324300

Mobile No.:

91-9820611471 (Mr. Abhijit Kale)

Fax No.:

Not Available

E-Mail :

symbio@symbiogenerics.com

Website:

http://www.symbiogenerics.com

 

 

Mumbai Office 1 :

#710, 7th Floor, Main Frame -1, A-Wing, Royal Palms, Aarey Colony, Goregaon (East), Mumbai - 400065, Maharashtra, India

Tel. No.:

91-22-28710151 – 53

Fax No.:

91-22-28710154

 

 

Mumbai Office 2 :

#215 Atrium, Unit- 622/ C-Wing, Andheri Kurla Road., Andheri (East), Mumbai - 400059, Maharashtra, India

Tel. No.:

91-22-28388880

 

 

Bangalore Office :

#87, 3rd Floor, Sector – 4, 14th Main, Opposite BDA Complex, HSR Layout, Bangalore – 560102, Karnataka, India

Tel. No.:

91-80-25723517

 

 

DIRECTORS

 

AS ON: 31.03.2017

 

Name :

Mr. Salim Sadiq Shaikh

Designation :

Director

Address :

N G Suncity, Phase 3, Building No.2/A, Flat No.801, Fareed Estate Thakur Village, Kandivali (East), Mumbai – 400101, Maharashtra, India

Date of Birth/Age :

04.03.1976

Mobile No.:

91-9920810208

E-Mail :

salim.shaikh@symbiogenerics.com

Date of Appointment :

30.05.2011

DIN No.:

03398407

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U24230KA2013PTC072419

COPERNICIUM PHARMACEUTICALS PRIVATE LIMITED

10/12/2013

U74900MH2013PTC245814

ACTINIC PHARMACEUTICALS PRIVATE LIMITED

17/07/2013

U74999MH2016PTC281980

PLAINVIEW PHARMACEUTICALS PRIVATE LIMITED

02/06/2016

U74999MH2017PTC299002

BLUMEN BIOVITALS HEALTHKARE PRIVATE LIMITED

24/08/2017

U74999TN2017PTC119375

SYMBIO NATURAL PRODUCTS PRIVATE LIMITED

03/11/2017

 

 

Name :

Mr. Abhijit Govindrao Kale

Designation :

Director

Address :

903, 9th Floor, Brighton Tower, Hari Om Nagar, Opposite E.E. Highway, Mulund (East), Mumbai – 400081, Maharashtra, India

Date of Birth/Age :

09.02.1973

Mobile No.:

91-9820611471

E-Mail :

abhijit.kale@symbiogenerics.com

Date of Appointment :

30.05.2011

DIN No.:

03398414

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U24230KA2013PTC072419

COPERNICIUM PHARMACEUTICALS PRIVATE LIMITED

10/12/2013

U74900MH2013PTC245814

ACTINIC PHARMACEUTICALS PRIVATE LIMITED

17/07/2013

U74999MH2016PTC281980

PLAINVIEW PHARMACEUTICALS PRIVATE LIMITED

02/06/2016

U74999MH2017PTC299002

BLUMEN BIOVITALS HEALTHKARE PRIVATE LIMITED

24/08/2017

U74999TN2017PTC119375

SYMBIO NATURAL PRODUCTS PRIVATE LIMITED

03/11/2017

 

 

Name :

Ms. Lakshmi Reddy Devalla

Designation :

Director

Address :

D-1, Sudarsan Gardens, 102, Velachery Road, Guindy, Chennai – 600032, Tamilnadu, India

Date of Birth/Age :

18.10.1966

Date of Appointment :

30.05.2011

DIN No.:

03410253

 

 

Name :

Mr. Akash Suresh Puranik

Designation :

Director

Address :

2023, 2nd Floor, Prestige South Ridge 100 Feet Road, Bsk 3rd Stage, Bangalore-560085, Karnataka, India

Date of Appointment :

30.09.2017

DIN No.:

06775891

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U24230KA2013PTC072419

COPERNICIUM PHARMACEUTICALS PRIVATE LIMITED

23/12/2013

U74999MH2017PTC299002

BLUMEN BIOVITALS HEALTHKARE PRIVATE LIMITED

24/08/2017

U74999TN2017PTC119375

SYMBIO NATURAL PRODUCTS PRIVATE LIMITED

03/11/2017

 

 

KEY EXECUTIVES

 

Name :

Mr. Venkat Raman

Designation :

Officer

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON: 31.03.2017

 

Names of Shareholders

 

No. of Shares

 

Abhijit Govindrao Kale

 

330000

Lakshmi Reddy Devalla

 

330000

Salim Sadiq Shaikh

 

330000

 

 

 

Total

 

 

990000

 

 

AS ON: 30.09.2017

 

Equity Share Breakup

Percentage of Holding

Category

 

Promoters – Individual/ Hindu Undivided Family – Indian

100.00

 

 

Total

 

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Wholesale Trader of Pharmaceuticals, Nutraceuticals, feed and food supplements, feed additives, serum, bulk drugs and intermediate. [Registered Activity]

 

 

Products/ Services :

ITC Code No.

 

Product Descriptions

99612730

Pharmaceutical products

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

 

Selling :

Not Divulged

 

 

Purchasing :

Not Divulged

 

PRODUCTION STATUS: (NOT AVAILABLE)

 

 

GENERAL INFORMATION

 

Suppliers :

Reference:

Not Divulged

Name of the Person (Designation):

--

Contact Number:

--

Since how long known:

--

Maximum limit dealt:

--

Experience:

--

Remark

--

 

 

Customers :

 

Reference:

Not Divulged

Name of the Person (Designation):

--

Contact Number:

--

Since how long known:

--

Maximum limit dealt:

--

Experience:

--

Remark

--

 

 

No. of Employees :

Not Divulged

 

 

Bankers :

·         Axis Bank Limited

Corporate Banking Branch No.192 Anna Salai, Chennai-600002, Tamilnadu, India

 

 

Facilities :

SECURED LOANS

31.03.2017

(INR In Million)

31.03.2016

(INR In Million)

LONG-TERM BORROWINGS

 

 

Term Loans From Kotak Mahindra Prime Limited

(Secured against hypothecation of Volkswagen Jetta car)

0.680

1.295

 

 

 

 

 

 

SHORT TERM BORROWINGS

 

 

Cash Credit from Axis Bank Limited

-Secured against hypothecation of Entire current assets of the company

-Secured against mortgage of properties by directors and executives

-Personally Guarantees by all Directors and above property owners

55.197

0.000

 

 

 

Total

 

55.877

1.295

 

 

 

Auditors :

 

Name :

K Kishore and Company

Chartered Accountants

Address :

No.7D, 7th Floor, Ega Trade Centre, 318, Poonamallee High Road, Kilpauk, Chennai-600010, Tamilnadu, India

Tel. No.:

91-44-26402065/ 42858099

E-Mail :

kkishore_co@yahoo.com

PAN No.:

AANFK1728L

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Firm in which directors are partners :

Celeste Biotech

 

 

CAPITAL STRUCTURE

 

AS ON: 31.03.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

3000000

Equity Shares

INR 10/- each

INR 30.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

990000

Equity Shares

INR 10/- each

INR 9.900 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

9.900

0.900

0.900

(b) Reserves & Surplus

51.058

32.680

16.099

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

60.958

33.580

16.999

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

0.680

1.295

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

0.680

1.295

0.000

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

65.097

9.200

6.200

(b) Trade payables

202.857

200.896

130.112

(c) Other current liabilities

7.221

19.560

10.890

(d) Short-term provisions

13.785

8.538

6.040

Total Current Liabilities (4)

288.960

238.194

153.242

 

 

 

 

TOTAL

350.598

273.069

170.241

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

2.106

1.912

0.317

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.256

0.185

0.054

(d)  Long-term Loan and Advances

1.800

0.400

0.150

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

4.162

2.497

0.521

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

81.467

84.706

25.554

(c) Trade receivables

240.691

159.877

130.527

(d) Cash and cash equivalents

2.879

10.039

7.383

(e) Short-term loans and advances

21.399

15.950

6.256

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

346.436

270.572

169.720

 

 

 

 

TOTAL

350.598

273.069

170.241

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

 

Revenue from Operations

847.843

480.823

230.752

 

 

Other Income

13.314

27.565

20.754

 

 

TOTAL                                    

861.157

508.388

251.506

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Purchases of Stock-in-Trade

747.587

484.697

213.482

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

-1.397

(51.558)

 

 

(18.178)

 

 

 

 

Employees benefits expense

30.578

28.611

26.405

 

 

Other expenses

37.165

19.940

11.054

 

 

TOTAL                                    

813.933

481.690

232.763

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

47.224

26.698

18.743

 

 

 

 

 

Less

FINANCIAL EXPENSES                       

4.995

0.388

0.000

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION              

42.229

26.310

18.743

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

0.767

0.934

0.295

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX                        

41.462

25.376

18.448

 

 

 

 

 

Less

TAX                                                                 

14.083

8.796

5.983

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX               

27.379

16.580

12.465

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

F.O.B. Value of Exports

12.872

109.845

77.602

 

TOTAL EARNINGS

12.872

109.845

77.602

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Traded goods

303.299

194.028

101.020

 

TOTAL IMPORTS

303.299

194.028

101.020

 

 

 

 

 

 

Earnings/ (Loss) Per Share (INR)

27.66

184.22

138.50

 

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

NA

NA

NA

 

 

 

 

Cash generated from operations

(44.499)

10.207

9.782

 

 

 

 

Net cash from operating activities

(58.653)

1.280

3.742

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

103.62

121.37

206.47

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

3.52

3.01

1.77

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

99.04

151.28

222.46

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

0.58

0.32

0.73

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

22.42

13.96

59.13

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.83

0.88

0.90

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

1.08

0.31

0.36

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

4.74

7.09

9.01

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.03

0.06

0.02

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

9.45

68.81

0.00

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

((PAT / Sales) * 100)

%

3.23

3.45

5.40

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

7.81

6.07

7.32

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

44.91

49.37

73.33

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

1.20

1.14

1.11

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.92

0.78

0.94

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.17

0.12

0.10

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

6.64

11.66

6.89

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.20

1.14

1.11

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 


 

 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Share Capital

0.900

0.900

9.900

Reserves & Surplus

16.099

32.680

51.058

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

16.999

33.580

60.958

 

 

 

 

long-term borrowings

0.000

1.295

0.680

Short term borrowings

6.200

9.200

65.097

Total borrowings

6.200

10.495

65.777

Debt/Equity ratio

0.365

0.313

1.079

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

230.752

480.823

847.843

 

 

108.372

76.332

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

230.752

480.823

847.843

Profit

12.465

16.580

27.379

 

5.40%

3.45%

3.23%

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report

(Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

INDEX OF CHARGES

 

SNO

SRN

CHARGE ID

CHARGE HOLDER NAME

DATE OF CREATION

DATE OF MODIFICATION

DATE OF SATISFACTION

AMOUNT

ADDRESS

1

G77958346

100050277

Axis Bank Limited

20/08/2016

19/01/2018

-

80000000.0

Corporate Banking BranchNo.192 Anna SalaiChennaiTN600002IN

 

 

UNSECURED LOANS

 

PARTICULARS

31.03.2017

(INR In Million)

31.03.2016

(INR In Million)

SHORT TERM BORROWINGS

 

 

Unsecured Loans from directors (repayable on demand)

9.900

9.200

 

 

 

Total

 

9.900

9.200

 

 

STATE OF COMPANY’S AFFAIRS AND FUTURE OUTLOOK

 

During the year the company could achieve a revenue of INR 861.156 million and profit after tax of INR 27.379 Million. The directors are optimistic of achieving higher turnover during financial year 2017-18.

 

 

CHANGE OF ADDRESS:

 

The Registered address of the company has been shifted from Cisons Complex, Shop No.77, 1st Floor, Door No.2 (Old No.150), Montieth Road, Egmore, Chennai – 600 008, Tamilnadu, India to the present address w.e.f 01.04.2013


FIXED ASSETS:

 

Tangible Assets

 

·         Office Equipment

·         Furniture

·         Computers and Accessories

·         Vehicles

 

 

 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 66.77

UK Pound

1

INR 90.58

Euro

1

INR 79.97

 

 

INFORMATION DETAILS

 

Information Gathered by :

TEJ

 

 

Analysis Done by :

PRY

 

 

Report Prepared by :

IND

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.